Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02868489 · ClinicalTrials.gov registry record · NA
Effect of Bacillus Coagulans and Galactomannans on Obese Patients Undergoing Sleeve Gastrectomy
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02868489 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 60 participants.
The verdict
NCT02868489, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the effect of bacillus coagulans and galactomannans (LactoWise®) administration on obese patients undergoing sleeve gastrectomy by observing standard protocol measurements in patients following sleeve gastrectomy: laboratory measurements, ideal body weight, and percent estimated weight loss, in addition incorporating the Gastrointestinal Quality of Life Index (GIQLI)
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT LactoWise®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-12-07 |
| Est. Completion | 2017-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02868489
The ClinicalTrials.gov registry entry for NCT02868489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02868489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02868489 about?
NCT02868489 is a clinical study titled "Effect of Bacillus Coagulans and Galactomannans on Obese Patients Undergoing Sleeve Gastrectomy". The purpose of the study is to determine the effect of bacillus coagulans and galactomannans (LactoWise®) administration on obese patients undergoing sleeve gastrectomy by observing standard protocol measurements in patients following sleeve gastrectomy: laboratory measurements, ideal body weight, a...
What is the current status of trial NCT02868489?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-12-07. Estimated completion is 2017-11-29.
What interventions are being tested in trial NCT02868489?
The interventions under investigation include: Placebo (OTHER), LactoWise® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02868489?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.